Cytokeratin profiles identify diagnostic signatures in colorectal cancer using multiplex analysis of tissue microarrays

Cellular Oncology

Volumn 28, Issue 4, 2006, Pages 167-175

  Knösel, Thomas ^a   Emde, Valeska ^a   Schlüns, Karsten ^a   Schlag, Peter Michael ^a   Dietel, Manfred ^a   Petersen, Iver ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Colorectal cancer (CRC); Cytokeratins; Epithelial mesenchymal transition (EMT); Hierarchical clustering; Prognosis; Tissue microarray (TMA)

Indexed keywords

CYTOKERATIN; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE MICROARRAY;

CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; HUMANS; KERATINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748917425     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. T. Brabletz, F. Hlubek, S. Spaderna, O. Schmalhofer, E. Hiendlmeyer, A. Jung and T. Kirchner, Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin, Cells Tissues Organs 179 (2005), 56-65.
2. L. Bubendorf, A. Nocito, H. Moch and G. Sauter, Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies, J. Pathol. 195 (1) (2001), 72-79.
3. H. Buhler and G. Schaller, Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesion proteins and dramatic regression of malignancy in vitro and in vivo, Mol. Cancer Res. 3 (2005), 365-371.
4. P.G. Chu and L.M. Weiss, Keratin expression in human tissues and neoplasms, Histopathology 40 (2002), 403-439.
5. D.C. Chung, Molecular prognostic markers and colorectal cancer: The search goes on, Gastroenterology 114 (1998), 1330-1332.
6. P.A. Coulombe, M.E. Hutton, A. Letai, A. Hebert, A.S. Paller and E. Fuchs, Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses, Cell 66 (1991), 1301-1311.
7. M.B. Eisen, P.T. Spellman, P.O. Brown and D. Botstein, Cluster analysis and display of genome-wide expression patterns, Proc. Natl. Acad. Sci. USA 95 (1998), 14863-14868.
8. E. Fuchs and D.W. Cleveland, A structural scaffolding of intermediate filaments in health and disease, Science 279 (1998), 514-519.
9. E. Galanis, S.R. Alberts and M.J. O'Connel, New adjuvant therapy for colon cancer: justified hope or commercial hype, Surg. Oncol. Clin. North Am. 9 (2000), 813-823.
10. M. Hesse, T.M. Magin and K. Weber, Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18, J. Cell Sci. 114 (2001), 2569-2565.
11. A. Jemal, A. Thomas, T. Murray and M. Thun, Cancer statistics 2002, CA Cancer J. Clin. 52 (2002), 23-47.
12. T. Knösel, A. Emde, K. Schlüns, Y. Chen, K. Jürchott, M. Krause, M. Dietel and I. Petersen, Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer, Neoplasia 7 (2005), 741-747.
13. T. Knösel, K. Schlüns, U. Stein, H. Schwabe, P.M. Schlag, M. Dietel and I. Petersen, Genetic imbalances with impact on survival in colorectal cancer patients, Histopathology 43 (2003) 323-331.
14. T. Knösel, Y. Yu, U. Stein, H. Schwabe, K. Schluns, P.M. Schlag, M. Dietel and I. Petersen, Overexpression of cyclooxygenase-2 correlates with chromosomal gain at the cyclooxygenase-2 locus and decreased patient survival in advanced colorectal carcinomas, Dis. Colon Rectum. 47 (2004), 70-77.
15. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, G. Sauter and O.P. Kallioniemi, Tissue microarrays for high-throughput molecular profiling of tumour specimens, Nat. Med. 4 (1998), 844-847.
16. E. Korsching, J. Packeisen, C. Liedtke, D. Hungermann, P. Wulfing, P.J. van Diest, B. Brandt, W. Boecker and H. Buerger, The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?, J. Pathol. 206 (2005), 451-457.
17. J.S. Macdonald, Adjuvant therapy of colon cancer, CA Cancer J. Clin. 49 (1999), 202-219.
18. R. Moll, W.W. Franke, D.L. Schiller, B. Geiger and R. Krepler, The catalog of human cytokeratins: patterns of expression in normal epithelia, tumours, and cultured cells, Cell 31 (1982), 11-24.
19. M.J. O'Connel, D.J. Schaid, V. Ganju, J. Cunningham, J.S. Kovach and S.N. Thibodeau, Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis?, Cancer 70 Suppl. (1992), 1732-1739.
20. P. Savagner, Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition, Bioessays 23 (2001), 912-923.
21. G. Schaller, I. Fuchs, W. Pritze, A. Ebert, H. Herbst, K. Pantel, H. Weitzel and E. Lengyel, Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer, Clin. Cancer Res. 2 (1996), 1879-1885.
22. H. Takei, Y. Iino, J. Horiguchi, T. Kanoh, Y. Takao, T. Oyama and Y. Morishita, Immunohistochemical analysis of cytokeratin #8 as a prognostic factor ininvasive breast carcinoma, Anticancer Res. 15 (1995), 1101-1105.